Other Lupus News

July 2, 2014

Animal research shows that an investigational drug that blocks the enzyme Cdk5 might help reduce the injury that can result following a stroke, a potential complication of lupus.

June 30, 2014

The FDA has granted Breakthrough Therapy Designation to idarucizumab, a potential antidote for the anticoagulant Pradaxa. Many lupus patients receive anticoagulation; new oral anticoagulants like Pradaxa are effective but can be dangerous because their anticoagulant event cannot be reversed if patients start to bleed.

May 21, 2014

It’s International Clinical Trials Day. Watch the new AllTrials campaign video. And change something.  

May 15, 2014

MedPage Today writer Nancy Walsh reports on a U.K. study showing that patients with lupus and other autoimmune diseases as well as certain other chronic conditions are at increased risk for shingles. While higher among older patients, the risk for shingles is still higher among younger people with lupus.

May 13, 2014

Task force agrees vitamin K antagonists like warfarin remain the mainstay of anticoagulation for antiphospholipid syndrome and says rituximab and hydroxychloroquine can be useful in some cases.

May 13, 2014

Rheumatology Network reports: An international task force of multi-speciality experts says the "treat-to-target" approach can be applied just as effectively in systemic lupus erythematosus (SLE) as it has proven in rheumatoid arthritis.

May 5, 2014

Source: Oklahoma Medical Research Foundation

A new discovery from scientists at OMRF could be used by physicians to predict and prevent lupus flares…

April 30, 2014

African-American women with lupus are at increased risk for adverse pregnancy outcomes, even before they are diagnosed with the disease, a retrospective study found.

April 25, 2014

New results of a Phase 2 study showed beneficial effects of the investigational B-cell inhibitor blisibimod among patients with severe lupus disease